CLINICAL_TRIALS
trial_result
· 2026-01-26
Clinical Trial Update: DPCP for the Treatment of Alopecia Areata [Phase 3]
Summary
Phase 3 trial of Diphenylcyclopropenone (DPCP) for alopecia areata was terminated, with results posted on 2026-01-26.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Minnesota | Conditions: Alopecia Areata | Phase 3 | Status: TERMINATED | Results posted: 2026-01-26